查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1402004

到 2030 年的藥品福利管理市場預測：按服務、商業模式、最終用戶和地區進行的全球分析

Pharmacy Benefit Management Market Forecasts to 2030 - Global Analysis By Service, By Business Model, By End User and By Geography
出版日期: | 出版商: Stratistics Market Research Consulting | 英文 200+ Pages | 商品交期: 2-3個工作天內

價格

根據 Stratistics MRC 的數據，2023 年全球藥品福利管理市場規模為 5,021 億美元，預測期內複合年成長率為 7.7%，到 2030 年將達到 8,439 億美元。

藥房福利管理 (PBM) 是一項管理健康保險計劃處方藥福利的服務。 PBM 尋求透過與藥房談判、管理處方箋和處理申請來最佳化藥物利用率並控制成本。 PBM 的作用是簡化藥物取得、提高負擔能力並促進高效的醫療保健服務。

根據醫療保險和醫療補助服務中心 (CMS) 醫療保險優勢登記文件，2023 年，美國有 3,080 萬人參加了醫療保險優勢計劃，佔醫療保險合格人口的 51.0%。

慢性病流行推動

全球慢性病負擔持續增加，增加了對藥物取得和用藥醫囑遵從性的有效管理的需求。 PBM 透過協商藥品價格、最佳化處方以及實施與慢性病治療相關的成本控制策略，在這方面發揮著至關重要的作用。 PBM 的重點是透過個人化的藥物治療方案改善患者的治療結果，與不斷變化的醫療保健格局保持一致，解決慢性病的複雜性和不斷成長的具有長期健康需求的人口。確保以具有成本效益的方式獲得藥物已變得至關重要人們健康所需的藥物。

藥價缺乏透明度

這種不透明的定價機制給消費者和 PBM 帶來了了解藥品真實成本的挑戰。由於複雜的回扣結構以及 PBM 和藥品製造商之間的私人價格談判，相關人員常常難以理解處方藥的實際價值。這種缺乏透明度不僅阻礙了資訊的決策，而且還降低了對醫療保健系統的信任。患者可能被迫支付高額自付費用，PBM 可能難以有效協商和管理藥品成本。

支持政策及政策

各國政府越來越認知到 PBM 在提高醫療保健效率和控制藥品成本方面發揮的關鍵作用，有利的法律規範可以促進市場成長。促進 PBM 領域透明度、公平競爭和標準化的政策創造了一個促進創新和協作的環境。透過使法規與醫療保健系統不斷變化的需求保持一致，政策制定者可以授權 PBM 最佳化處方藥福利，最終使患者和提供者受益。此類監管支持不僅將培育更具彈性和競爭力的 PBM 市場，而且有助於整體改善醫療保健的可負擔性和可近性。

缺乏標準化

由於藥品處方集、福利結構和報銷模式多樣化，缺乏統一性導致 PBM業務變得複雜。標準化的缺乏會抑制互通性，並阻礙醫療保健生態系統中各個相關人員之間的無縫資訊交流。它還在比較和基準化 PBM實績方面帶來了挑戰，限制了透明度並阻礙了最佳實踐的建立。此外，缺乏標準化流程可能會導致效率低下和錯誤，從而影響護理品質和患者治療結果。

COVID-19 的影響：

COVID-19 的爆發對藥品福利管理 (PBM) 市場產生了多方面的影響。醫療保健需求的增加、藥物供應鏈的中斷以及病患行為的變化重塑了處方藥物管理的動態。遠端醫療的擴展、數位化的加速以及對公共衛生的重新關注凸顯了 PBM 在適應大流行帶來的挑戰方面不斷變化的作用。雖然這場危機刺激了創新，但也凸顯了需要有彈性和靈活的 PBM 策略來駕馭當前的醫療保健形勢。

專業藥房服務業預計將在預測期內成為最大的行業。

透過滿足需要複雜且高成本的慢性病和罕見疾病藥物治療的患者的獨特需求，專業藥房服務產業有望實現良好的成長。這些服務最佳化了專業藥物的獲取，並確保及時給藥、病患教育和全面支持。提供專業藥局服務的 PBM 有助於提高用藥醫囑遵從性、控制成本並改善病患治療效果，在快速發展的藥品福利領域展現了對個體化照護的重要承諾。

預計零售藥局領域在預測期內複合年成長率最高

預計零售藥局領域在預測期內將以最快的複合年成長率成長。 PBM 與零售藥局合作，最佳化處方藥福利、協商價格並簡化申請處理。這種夥伴關係將確保患者方便地獲得藥物，同時提高醫療保健系統的成本效益和效率。零售藥局是 PBM 生態系統中的關鍵參與者，有助於實現向廣大人群提供負擔得起且易於獲得的藥物服務的總體目標。

佔有率最大的地區

由於強大的醫療基礎設施、高昂的醫療成本和沈重的慢性病負擔，北美在預測期內佔據了最大的市場佔有率。該地區完善的法規環境和健康保險普及正在增加 PBM 的存在。此外，隨著對成本控制的持續重視以及醫療保健領域先進技術的整合進一步促進了 PBM 的成長，北美已成為塑造藥品福利管理服務發展的關鍵參與者。

複合年成長率最高的地區：

由於醫療保健意識提高、慢性病數量增加和保險覆蓋範圍擴大等多種因素，亞太地區在預測期內將呈現最高的複合年成長率。政府控制醫療成本和改善藥品取得的努力進一步推動了 PBM 的採用。該地區多元化且不斷成長的藥品市場為 PBM 提供了最佳化藥物效益的機會。然而，挑戰包括克服不同的監管環境和不同的醫療保健系統。隨著 PBM 獲得認可，亞太地區為尋求控制藥品成本和加強患者照護的公司呈現出充滿活力的前景。

免費客製化服務：

訂閱此報告的客戶可以存取以下免費自訂選項之一：

  • 公司簡介
    • 其他市場參與者的綜合分析（最多 3 家公司）
    • 主要企業SWOT分析（最多3家企業）
  • 區域分割
    • 根據客戶興趣對主要國家的市場估計、預測和複合年成長率（註：基於可行性檢查）
  • 競爭基準化分析
    • 根據產品系列、地理分佈和策略聯盟對主要企業基準化分析

目錄

第1章執行摘要

第2章 前言

  • 概述
  • 相關利益者
  • 調查範圍
  • 調查方法
    • 資料探勘
    • 資料分析
    • 資料檢驗
    • 研究途徑
  • 調查來源
    • 主要調查來源
    • 二次調查來源
    • 先決條件

第3章市場趨勢分析

  • 促進因素
  • 抑制因素
  • 機會
  • 威脅
  • 最終用戶分析
  • 新興市場
  • 新型冠狀病毒感染疾病（COVID-19）的影響

第4章波特五力分析

  • 供應商的議價能力
  • 買方議價能力
  • 替代品的威脅
  • 新進入者的威脅
  • 競爭公司之間的敵對關係

第5章全球藥品福利管理市場：依服務分類

  • 專業藥局服務
  • 社會福利計畫設計與管理
  • 藥局投訴處理
  • 處方管理
  • 其他

第6章全球藥品福利管理市場：依商業模式

  • 政府健康計劃
  • 雇主贊助的計劃
  • 健康保險管理

第7章全球藥品福利管理市場：依最終用戶分類

  • 藥品福利管理組織
  • 通訊藥房
  • 零售藥房
  • 其他最終用戶

第8章全球藥品福利管理市場：按地區

  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 德國
    • 英國
    • 義大利
    • 法國
    • 西班牙
    • 其他歐洲國家
  • 亞太地區
    • 日本
    • 中國
    • 印度
    • 澳洲
    • 紐西蘭
    • 韓國
    • 其他亞太地區
  • 南美洲
    • 阿根廷
    • 巴西
    • 智利
    • 南美洲其他地區
  • 中東和非洲
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 卡達
    • 南非
    • 其他中東和非洲

第9章 主要進展

  • 合約、夥伴關係、協作和合資企業
  • 收購和合併
  • 新產品發布
  • 業務擴展
  • 其他關鍵策略

第10章 公司簡介

  • Abarca Health LLC.
  • SS&C Technologies, Inc.
  • Anthem, Inc.
  • Benecard Services, LLC
  • CaptureRx
  • Centene Corporation
  • ProCare Rx
  • Change Healthcare
  • OptumRx, Inc.
  • Cigna
  • Medimpact
  • CVS Health
  • Elixir Rx Solutions, LLC
  • Express Scripts Holding Company
Product Code: SMRC24524

According to Stratistics MRC, the Global Pharmacy Benefit Management Market is accounted for $502.1 billion in 2023 and is expected to reach $843.9 billion by 2030 growing at a CAGR of 7.7% during the forecast period. Pharmacy Benefit Management (PBM) is a service that administers prescription drug benefits for health insurance plans. PBMs negotiate with pharmacies, manage formularies, and process claims, aiming to optimize drug utilization and control costs. Their role streamlines drug access, enhances affordability, and promotes efficient healthcare delivery.

According to the Centers for Medicare and Medicaid Services (CMS) Medicare Advantage Enrollment Files, 30.8 million people in the U.S. were enrolled in a Medicare Advantage plan, which accounted for 51.0% of the eligible Medicare population in 2023.

Market Dynamics:

Driver:

Growing prevalence of chronic conditions boosts

The global burden of chronic diseases continues to rise, there is an increased demand for efficient management of medication access and adherence. PBMs play a pivotal role in this landscape by negotiating drug prices, optimizing formularies, and implementing strategies to control costs associated with chronic disease treatments. Their focus on improving patient outcomes through personalized medication plans aligns with the evolving healthcare landscape, making PBMs essential in addressing the complexities of chronic conditions and ensuring cost-effective access to necessary medications for a growing population with long-term health needs.

Restraint:

Lack of transparency in drug pricing

This opacity in pricing mechanisms creates challenges for both consumers and PBMs in understanding the true cost of medications. With intricate rebate structures and undisclosed pricing negotiations between PBMs and pharmaceutical manufacturers, stakeholders often face difficulties in comprehending the actual value of prescribed drugs. This lack of transparency not only hampers informed decision-making but also diminishes trust in the healthcare system. Patients may bear the brunt of high out-of-pocket costs, while PBMs may struggle to effectively negotiate and manage drug expenses.

Opportunity:

Supportive policies and regulations

Governments increasingly recognize the pivotal role of PBMs in enhancing healthcare efficiency and controlling drug costs, favorable regulatory frameworks can stimulate market growth. Policies that promote transparency, fair competition, and standardization within the PBM sector create a conducive environment for innovation and collaboration. By aligning regulations with the evolving needs of healthcare systems, policymakers can empower PBMs to optimize prescription drug benefits, ultimately benefiting patients and healthcare providers. This regulatory support not only fosters a more resilient and competitive PBM market but also contributes to the overall improvement of healthcare affordability and accessibility.

Threat:

Lack of Standardization

With diverse drug formularies, benefit structures, and reimbursement models, the absence of uniformity introduces complexities in PBM practices. This lack of standardization can impede interoperability, hindering seamless information exchange among various stakeholders in the healthcare ecosystem. It also creates challenges in comparing and benchmarking PBM performance, limiting transparency and inhibiting the establishment of best practices. Moreover, the absence of standardized processes may lead to inefficiencies and errors, impacting the quality of care and patient outcomes.

COVID-19 Impact:

The COVID-19 pandemic has exerted a multifaceted impact on the Pharmacy Benefit Management (PBM) market. Increased healthcare demands, disruptions in the drug supply chain, and altered patient behavior have reshaped the dynamics of prescription drug management. Telehealth expansion, accelerated digitalization, and a renewed focus on public health underscore the evolving role of PBMs in adapting to the challenges posed by the pandemic. While the crisis has prompted innovation, it has also highlighted the need for resilient and flexible PBM strategies to navigate the ongoing healthcare landscape.

The specialty pharmacy services segment is expected to be the largest during the forecast period

The specialty pharmacy services segment is expected to have a lucrative growth by addressing the unique needs of patients requiring complex, high-cost medications for chronic and rare conditions. These services optimize access to specialty drugs, ensuring timely delivery, patient education, and comprehensive support. PBMs offering specialty pharmacy services enhance medication adherence, manage costs, and contribute to improved patient outcomes, demonstrating a vital commitment to personalized care in the rapidly evolving landscape of pharmaceutical benefits.

The retail pharmacies segment is expected to have the highest CAGR during the forecast period

The retail pharmacies segment is anticipated to witness the fastest CAGR growth during the forecast period. PBMs collaborate with retail pharmacies to optimize prescription drug benefits, negotiate pricing, and streamline claims processing. This partnership ensures convenient access to medications for patients while enhancing cost-effectiveness and efficiency in the healthcare system. Retail pharmacies, as key players in the PBM ecosystem, contribute to the overall goal of providing affordable and accessible pharmaceutical care to a broad population.

Region with largest share:

North America secures the largest share in the market over the forecast period driven by a robust healthcare infrastructure, high healthcare spending, and a significant burden of chronic diseases. The region's well-established regulatory environment and widespread adoption of health insurance contribute to the strong presence of PBMs. Moreover, the constant emphasis on cost containment and the integration of advanced technologies in healthcare further propel the growth of PBMs, making North America a key player in shaping the evolution of pharmacy benefit management services.

Region with highest CAGR:

The Asia Pacific region exhibits the highest CAGR in the market over the forecast period due to multiple factors driven by increasing healthcare awareness, rising chronic diseases and expanding insurance coverage. Governments' efforts to control healthcare costs and improve access to medications further propel PBM adoption. The region's diverse and growing pharmaceutical market offers opportunities for PBMs to optimize drug benefits. However, challenges include navigating varied regulatory landscapes and diverse healthcare systems. As PBM awareness rises, the Asia Pacific presents a dynamic landscape for companies aiming to enhance pharmaceutical cost management and patient care.

Key players in the market:

Some of the key players in Pharmacy Benefit Management market include Abarca Health LLC., SS&C Technologies, Inc., Anthem, Inc., Benecard Services, LLC, CaptureRx, Centene Corporation, ProCare Rx, Change Healthcare, OptumRx, Inc., Cigna, Medimpact, CVS Health, Elixir Rx Solutions, LLC and Express Scripts Holding Company.

Key Developments:

In July 2023, CVS Caremark announced a partnership with the discount drug service provider GoodRx to reduce out-of-pocket prescription costs for millions of people.

In October 2022, Omnicell, Inc., a provider of medication management and adherence tools for health systems and pharmacies, launched Specialty Pharmacy Services, a comprehensive offering designed to help health systems launch and/or optimize a fully managed, hospital-owned specialty pharmacy.

In March 2022, ProdigyRx, a pharmacy benefits manager, launched its business operations that offer PBM services and clinical solutions for workers' compensation insurers, third-party administrators, and self-insured/administered employers.

Services Covered:

  • Specialty Pharmacy Services
  • Benefit Plan Design & Administration
  • Pharmacy Claims Processing
  • Formulary Management
  • Other Services

Business Models Covered:

  • Government Health Programs
  • Employer-Sponsored Programs
  • Health Insurance Management

End Users Covered:

  • Pharmacy Benefit Management Organization
  • Mail Order Pharmacies
  • Retail Pharmacies
  • Other End Users

Regions Covered:

  • North America
    • US
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • Italy
    • France
    • Spain
    • Rest of Europe
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
    • New Zealand
    • South Korea
    • Rest of Asia Pacific
  • South America
    • Argentina
    • Brazil
    • Chile
    • Rest of South America
  • Middle East & Africa
    • Saudi Arabia
    • UAE
    • Qatar
    • South Africa
    • Rest of Middle East & Africa

What our report offers:

  • Market share assessments for the regional and country-level segments
  • Strategic recommendations for the new entrants
  • Covers Market data for the years 2021, 2022, 2023, 2026, and 2030
  • Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
  • Strategic recommendations in key business segments based on the market estimations
  • Competitive landscaping mapping the key common trends
  • Company profiling with detailed strategies, financials, and recent developments
  • Supply chain trends mapping the latest technological advancements

Free Customization Offerings:

All the customers of this report will be entitled to receive one of the following free customization options:

  • Company Profiling
    • Comprehensive profiling of additional market players (up to 3)
    • SWOT Analysis of key players (up to 3)
  • Regional Segmentation
    • Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
  • Competitive Benchmarking
    • Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

Table of Contents

1 Executive Summary

2 Preface

  • 2.1 Abstract
  • 2.2 Stake Holders
  • 2.3 Research Scope
  • 2.4 Research Methodology
    • 2.4.1 Data Mining
    • 2.4.2 Data Analysis
    • 2.4.3 Data Validation
    • 2.4.4 Research Approach
  • 2.5 Research Sources
    • 2.5.1 Primary Research Sources
    • 2.5.2 Secondary Research Sources
    • 2.5.3 Assumptions

3 Market Trend Analysis

  • 3.1 Introduction
  • 3.2 Drivers
  • 3.3 Restraints
  • 3.4 Opportunities
  • 3.5 Threats
  • 3.6 End User Analysis
  • 3.7 Emerging Markets
  • 3.8 Impact of Covid-19

4 Porters Five Force Analysis

  • 4.1 Bargaining power of suppliers
  • 4.2 Bargaining power of buyers
  • 4.3 Threat of substitutes
  • 4.4 Threat of new entrants
  • 4.5 Competitive rivalry

5 Global Pharmacy Benefit Management Market, By Service

  • 5.1 Introduction
  • 5.2 Specialty Pharmacy Services
  • 5.3 Benefit Plan Design & Administration
  • 5.4 Pharmacy Claims Processing
  • 5.5 Formulary Management
  • 5.6 Other Services

6 Global Pharmacy Benefit Management Market, By Business Model

  • 6.1 Introduction
  • 6.2 Government Health Programs
  • 6.3 Employer-Sponsored Programs
  • 6.4 Health Insurance Management

7 Global Pharmacy Benefit Management Market, By End User

  • 7.1 Introduction
  • 7.2 Pharmacy Benefit Management Organization
  • 7.3 Mail Order Pharmacies
  • 7.4 Retail Pharmacies
  • 7.5 Other End Users

8 Global Pharmacy Benefit Management Market, By Geography

  • 8.1 Introduction
  • 8.2 North America
    • 8.2.1 US
    • 8.2.2 Canada
    • 8.2.3 Mexico
  • 8.3 Europe
    • 8.3.1 Germany
    • 8.3.2 UK
    • 8.3.3 Italy
    • 8.3.4 France
    • 8.3.5 Spain
    • 8.3.6 Rest of Europe
  • 8.4 Asia Pacific
    • 8.4.1 Japan
    • 8.4.2 China
    • 8.4.3 India
    • 8.4.4 Australia
    • 8.4.5 New Zealand
    • 8.4.6 South Korea
    • 8.4.7 Rest of Asia Pacific
  • 8.5 South America
    • 8.5.1 Argentina
    • 8.5.2 Brazil
    • 8.5.3 Chile
    • 8.5.4 Rest of South America
  • 8.6 Middle East & Africa
    • 8.6.1 Saudi Arabia
    • 8.6.2 UAE
    • 8.6.3 Qatar
    • 8.6.4 South Africa
    • 8.6.5 Rest of Middle East & Africa

9 Key Developments

  • 9.1 Agreements, Partnerships, Collaborations and Joint Ventures
  • 9.2 Acquisitions & Mergers
  • 9.3 New Product Launch
  • 9.4 Expansions
  • 9.5 Other Key Strategies

10 Company Profiling

  • 10.1 Abarca Health LLC.
  • 10.2 SS&C Technologies, Inc.
  • 10.3 Anthem, Inc.
  • 10.4 Benecard Services, LLC
  • 10.5 CaptureRx
  • 10.6 Centene Corporation
  • 10.7 ProCare Rx
  • 10.8 Change Healthcare
  • 10.9 OptumRx, Inc.
  • 10.10 Cigna
  • 10.11 Medimpact
  • 10.12 CVS Health
  • 10.13 Elixir Rx Solutions, LLC
  • 10.14 Express Scripts Holding Company

List of Tables

  • Table 1 Global Pharmacy Benefit Management Market Outlook, By Region (2021-2030) ($MN)
  • Table 2 Global Pharmacy Benefit Management Market Outlook, By Service (2021-2030) ($MN)
  • Table 3 Global Pharmacy Benefit Management Market Outlook, By Specialty Pharmacy Services (2021-2030) ($MN)
  • Table 4 Global Pharmacy Benefit Management Market Outlook, By Benefit Plan Design & Administration (2021-2030) ($MN)
  • Table 5 Global Pharmacy Benefit Management Market Outlook, By Pharmacy Claims Processing (2021-2030) ($MN)
  • Table 6 Global Pharmacy Benefit Management Market Outlook, By Formulary Management (2021-2030) ($MN)
  • Table 7 Global Pharmacy Benefit Management Market Outlook, By Other Services (2021-2030) ($MN)
  • Table 8 Global Pharmacy Benefit Management Market Outlook, By Business Model (2021-2030) ($MN)
  • Table 9 Global Pharmacy Benefit Management Market Outlook, By Government Health Programs (2021-2030) ($MN)
  • Table 10 Global Pharmacy Benefit Management Market Outlook, By Employer-Sponsored Programs (2021-2030) ($MN)
  • Table 11 Global Pharmacy Benefit Management Market Outlook, By Health Insurance Management (2021-2030) ($MN)
  • Table 12 Global Pharmacy Benefit Management Market Outlook, By End User (2021-2030) ($MN)
  • Table 13 Global Pharmacy Benefit Management Market Outlook, By Pharmacy Benefit Management Organization (2021-2030) ($MN)
  • Table 14 Global Pharmacy Benefit Management Market Outlook, By Mail Order Pharmacies (2021-2030) ($MN)
  • Table 15 Global Pharmacy Benefit Management Market Outlook, By Retail Pharmacies (2021-2030) ($MN)
  • Table 16 Global Pharmacy Benefit Management Market Outlook, By Other End Users (2021-2030) ($MN)
  • Table 17 North America Pharmacy Benefit Management Market Outlook, By Country (2021-2030) ($MN)
  • Table 18 North America Pharmacy Benefit Management Market Outlook, By Service (2021-2030) ($MN)
  • Table 19 North America Pharmacy Benefit Management Market Outlook, By Specialty Pharmacy Services (2021-2030) ($MN)
  • Table 20 North America Pharmacy Benefit Management Market Outlook, By Benefit Plan Design & Administration (2021-2030) ($MN)
  • Table 21 North America Pharmacy Benefit Management Market Outlook, By Pharmacy Claims Processing (2021-2030) ($MN)
  • Table 22 North America Pharmacy Benefit Management Market Outlook, By Formulary Management (2021-2030) ($MN)
  • Table 23 North America Pharmacy Benefit Management Market Outlook, By Other Services (2021-2030) ($MN)
  • Table 24 North America Pharmacy Benefit Management Market Outlook, By Business Model (2021-2030) ($MN)
  • Table 25 North America Pharmacy Benefit Management Market Outlook, By Government Health Programs (2021-2030) ($MN)
  • Table 26 North America Pharmacy Benefit Management Market Outlook, By Employer-Sponsored Programs (2021-2030) ($MN)
  • Table 27 North America Pharmacy Benefit Management Market Outlook, By Health Insurance Management (2021-2030) ($MN)
  • Table 28 North America Pharmacy Benefit Management Market Outlook, By End User (2021-2030) ($MN)
  • Table 29 North America Pharmacy Benefit Management Market Outlook, By Pharmacy Benefit Management Organization (2021-2030) ($MN)
  • Table 30 North America Pharmacy Benefit Management Market Outlook, By Mail Order Pharmacies (2021-2030) ($MN)
  • Table 31 North America Pharmacy Benefit Management Market Outlook, By Retail Pharmacies (2021-2030) ($MN)
  • Table 32 North America Pharmacy Benefit Management Market Outlook, By Other End Users (2021-2030) ($MN)
  • Table 33 Europe Pharmacy Benefit Management Market Outlook, By Country (2021-2030) ($MN)
  • Table 34 Europe Pharmacy Benefit Management Market Outlook, By Service (2021-2030) ($MN)
  • Table 35 Europe Pharmacy Benefit Management Market Outlook, By Specialty Pharmacy Services (2021-2030) ($MN)
  • Table 36 Europe Pharmacy Benefit Management Market Outlook, By Benefit Plan Design & Administration (2021-2030) ($MN)
  • Table 37 Europe Pharmacy Benefit Management Market Outlook, By Pharmacy Claims Processing (2021-2030) ($MN)
  • Table 38 Europe Pharmacy Benefit Management Market Outlook, By Formulary Management (2021-2030) ($MN)
  • Table 39 Europe Pharmacy Benefit Management Market Outlook, By Other Services (2021-2030) ($MN)
  • Table 40 Europe Pharmacy Benefit Management Market Outlook, By Business Model (2021-2030) ($MN)
  • Table 41 Europe Pharmacy Benefit Management Market Outlook, By Government Health Programs (2021-2030) ($MN)
  • Table 42 Europe Pharmacy Benefit Management Market Outlook, By Employer-Sponsored Programs (2021-2030) ($MN)
  • Table 43 Europe Pharmacy Benefit Management Market Outlook, By Health Insurance Management (2021-2030) ($MN)
  • Table 44 Europe Pharmacy Benefit Management Market Outlook, By End User (2021-2030) ($MN)
  • Table 45 Europe Pharmacy Benefit Management Market Outlook, By Pharmacy Benefit Management Organization (2021-2030) ($MN)
  • Table 46 Europe Pharmacy Benefit Management Market Outlook, By Mail Order Pharmacies (2021-2030) ($MN)
  • Table 47 Europe Pharmacy Benefit Management Market Outlook, By Retail Pharmacies (2021-2030) ($MN)
  • Table 48 Europe Pharmacy Benefit Management Market Outlook, By Other End Users (2021-2030) ($MN)
  • Table 49 Asia Pacific Pharmacy Benefit Management Market Outlook, By Country (2021-2030) ($MN)
  • Table 50 Asia Pacific Pharmacy Benefit Management Market Outlook, By Service (2021-2030) ($MN)
  • Table 51 Asia Pacific Pharmacy Benefit Management Market Outlook, By Specialty Pharmacy Services (2021-2030) ($MN)
  • Table 52 Asia Pacific Pharmacy Benefit Management Market Outlook, By Benefit Plan Design & Administration (2021-2030) ($MN)
  • Table 53 Asia Pacific Pharmacy Benefit Management Market Outlook, By Pharmacy Claims Processing (2021-2030) ($MN)
  • Table 54 Asia Pacific Pharmacy Benefit Management Market Outlook, By Formulary Management (2021-2030) ($MN)
  • Table 55 Asia Pacific Pharmacy Benefit Management Market Outlook, By Other Services (2021-2030) ($MN)
  • Table 56 Asia Pacific Pharmacy Benefit Management Market Outlook, By Business Model (2021-2030) ($MN)
  • Table 57 Asia Pacific Pharmacy Benefit Management Market Outlook, By Government Health Programs (2021-2030) ($MN)
  • Table 58 Asia Pacific Pharmacy Benefit Management Market Outlook, By Employer-Sponsored Programs (2021-2030) ($MN)
  • Table 59 Asia Pacific Pharmacy Benefit Management Market Outlook, By Health Insurance Management (2021-2030) ($MN)
  • Table 60 Asia Pacific Pharmacy Benefit Management Market Outlook, By End User (2021-2030) ($MN)
  • Table 61 Asia Pacific Pharmacy Benefit Management Market Outlook, By Pharmacy Benefit Management Organization (2021-2030) ($MN)
  • Table 62 Asia Pacific Pharmacy Benefit Management Market Outlook, By Mail Order Pharmacies (2021-2030) ($MN)
  • Table 63 Asia Pacific Pharmacy Benefit Management Market Outlook, By Retail Pharmacies (2021-2030) ($MN)
  • Table 64 Asia Pacific Pharmacy Benefit Management Market Outlook, By Other End Users (2021-2030) ($MN)
  • Table 65 South America Pharmacy Benefit Management Market Outlook, By Country (2021-2030) ($MN)
  • Table 66 South America Pharmacy Benefit Management Market Outlook, By Service (2021-2030) ($MN)
  • Table 67 South America Pharmacy Benefit Management Market Outlook, By Specialty Pharmacy Services (2021-2030) ($MN)
  • Table 68 South America Pharmacy Benefit Management Market Outlook, By Benefit Plan Design & Administration (2021-2030) ($MN)
  • Table 69 South America Pharmacy Benefit Management Market Outlook, By Pharmacy Claims Processing (2021-2030) ($MN)
  • Table 70 South America Pharmacy Benefit Management Market Outlook, By Formulary Management (2021-2030) ($MN)
  • Table 71 South America Pharmacy Benefit Management Market Outlook, By Other Services (2021-2030) ($MN)
  • Table 72 South America Pharmacy Benefit Management Market Outlook, By Business Model (2021-2030) ($MN)
  • Table 73 South America Pharmacy Benefit Management Market Outlook, By Government Health Programs (2021-2030) ($MN)
  • Table 74 South America Pharmacy Benefit Management Market Outlook, By Employer-Sponsored Programs (2021-2030) ($MN)
  • Table 75 South America Pharmacy Benefit Management Market Outlook, By Health Insurance Management (2021-2030) ($MN)
  • Table 76 South America Pharmacy Benefit Management Market Outlook, By End User (2021-2030) ($MN)
  • Table 77 South America Pharmacy Benefit Management Market Outlook, By Pharmacy Benefit Management Organization (2021-2030) ($MN)
  • Table 78 South America Pharmacy Benefit Management Market Outlook, By Mail Order Pharmacies (2021-2030) ($MN)
  • Table 79 South America Pharmacy Benefit Management Market Outlook, By Retail Pharmacies (2021-2030) ($MN)
  • Table 80 South America Pharmacy Benefit Management Market Outlook, By Other End Users (2021-2030) ($MN)
  • Table 81 Middle East & Africa Pharmacy Benefit Management Market Outlook, By Country (2021-2030) ($MN)
  • Table 82 Middle East & Africa Pharmacy Benefit Management Market Outlook, By Service (2021-2030) ($MN)
  • Table 83 Middle East & Africa Pharmacy Benefit Management Market Outlook, By Specialty Pharmacy Services (2021-2030) ($MN)
  • Table 84 Middle East & Africa Pharmacy Benefit Management Market Outlook, By Benefit Plan Design & Administration (2021-2030) ($MN)
  • Table 85 Middle East & Africa Pharmacy Benefit Management Market Outlook, By Pharmacy Claims Processing (2021-2030) ($MN)
  • Table 86 Middle East & Africa Pharmacy Benefit Management Market Outlook, By Formulary Management (2021-2030) ($MN)
  • Table 87 Middle East & Africa Pharmacy Benefit Management Market Outlook, By Other Services (2021-2030) ($MN)
  • Table 88 Middle East & Africa Pharmacy Benefit Management Market Outlook, By Business Model (2021-2030) ($MN)
  • Table 89 Middle East & Africa Pharmacy Benefit Management Market Outlook, By Government Health Programs (2021-2030) ($MN)
  • Table 90 Middle East & Africa Pharmacy Benefit Management Market Outlook, By Employer-Sponsored Programs (2021-2030) ($MN)
  • Table 91 Middle East & Africa Pharmacy Benefit Management Market Outlook, By Health Insurance Management (2021-2030) ($MN)
  • Table 92 Middle East & Africa Pharmacy Benefit Management Market Outlook, By End User (2021-2030) ($MN)
  • Table 93 Middle East & Africa Pharmacy Benefit Management Market Outlook, By Pharmacy Benefit Management Organization (2021-2030) ($MN)
  • Table 94 Middle East & Africa Pharmacy Benefit Management Market Outlook, By Mail Order Pharmacies (2021-2030) ($MN)
  • Table 95 Middle East & Africa Pharmacy Benefit Management Market Outlook, By Retail Pharmacies (2021-2030) ($MN)
  • Table 96 Middle East & Africa Pharmacy Benefit Management Market Outlook, By Other End Users (2021-2030) ($MN)